![]() |
|
|
Vol. 285, Issue 3, 1260-1265, June 1998
Graduate School of Pharmaceutical Sciences, The University of Tokyo, Hongo, Bunkyo-ku, Tokyo 113, Japan (H.K., H.S., Y.S.) and Institute of Molecular and Cellular Biosciences, The University of Tokyo, Yayoi, Bunkyo-ku, Tokyo 113, Japan (M.N., T.T.)
| |
Abstract |
|---|
|
|
|---|
Cumulative evidence suggests that several organic anions are actively effluxed from the brain to the blood across the blood-brain barrier (BBB). We examined the possibility of the presence of primary active transporters for organic anions (multidrug resistance associated protein (MRP) and canalicular multispecific organic anion transporter (cMOAT)) on the BBB by measuring the ATP-dependent uptake of 2,4-dinitrophenyl-S-glutathione (DNP-SG) and leukotriene C4 (LTC4) into membrane vesicles prepared from a cell line derived from mouse brain capillary endothelial cells (MBEC4). The ATP-dependent uptake of DNP-SG into the membrane vesicles was osmotically sensitive and was also supported by GTP, but not by AMP or ADP. An ATPase inhibitor, vanadate, blocked the ATP-dependent uptake of DNP-SG. The ATP-dependent uptake process was saturable, with Km values of 0.56 and 0.22 µM, and Vmax values of 5.5 and 27.5 pmol/min/mg protein for DNP-SG and LTC4, respectively. Northern and Western blot analyses showed the expression of murine MRP but not cMOAT in MBEC4 cells. Western blot analysis of the rat cerebral endothelial cells indicated the expression of protein(s) that is detectable with MRPr1, an antibody against MRP. These results, together with previous findings that both DNP-SG and LTC4 are good ligands for MRP, suggest that MRP is responsible for the unidirectional, energy-dependent efflux of organic anions from the brain into the circulating blood across the BBB.
| |
Introduction |
|---|
|
|
|---|
The
brain uptake of compounds is restricted by the BBB that acts as a
shield to protect the brain. The BBB is formed by the tight junction,
an anatomical feature of brain capillary endothelial cells, which
connects them to each other (Bradbury, 1979
; Pardridge, 1991
; Rapoport,
1976
). Because the molecules in the circulating blood have to be
transported across the cerebral endothelial cells transcellularly to
enter the brain due to the presence of the tight junction and the
paucity of fenestra or pinocytotic vesicles, the brain penetration of
compounds particularly those with high hydrophilicity and/or high
molecular weight is restricted (Bradbury, 1979
; Pardridge, 1991
;
Rapoport, 1976
). Although several cationic or neutral compounds are
lipophilic, their penetration into the brain is restricted by P-gp, a
primary active transporter on the luminal membrane of the cerebral
endothelial cells that extrudes cationic or neutral compounds from the
brain into the circulating blood (Tamai and Tsuji, 1996
; Tatsuta
et al., 1992
; Schinkel et al., 1994
).
In addition, cumulative evidence suggests that several organic anions
are transported from the brain to the blood across the BBB (Suzuki
et al., 1997
); Leininger et al. (1991)
indicated
that the elimination of 1-naphthyl-
-D-glucuronide after
microinjection into the cerebral cortex is mediated by a saturable
process. We also analyzed the time profiles of the brain concentrations
of an anionic
-lactam antibiotic, cefodizime after i.v.
administration and found that this compound is actively transported
from the brain to the blood across the BBB (Matsushita et
al., 1991
). The fact that both
1-naphthyl-
-D-glucuronide and cefodizime are substrates for the primary active transporter for organic anions located on the
bile canalicular membrane (cMOAT) (Kobayashi et al., 1990
; Kusuhara et al., in press; Sathirakul et al.,
1994
; Yamazaki et al., 1993
) prompts us to hypothesize that
cMOAT and/or its related transporter(s) may be expressed on the BBB.
Our purpose is to examine this hypothesis in an in vitro
model for studying ligand transport across the BBB. As a cell line, we
used MBEC4 cells, established by infecting isolated mouse cerebral endothelial cells with SV40 (Tatsuta et al., 1992
). Because
1) MBEC4 cells retain properties specific to cerebral endothelial cells
in the brain such as the expression of acetyl low-density lipoprotein
receptors,
-glutamyl transpeptidase and alkaline phosphatase, 2) a
monolayer of MBEC4 cells with little paracellular leakage can be formed
with the localized luminal expression of P-gp, this cell line has been
used to characterize the transport properties of P-gp located on the
BBB (Tatsuta et al., 1992
). In our study, we examined the
ATP-dependent uptake of DNP-SG and LTC4, typical
substrates for primary active transporters (such as cMOAT and MRP)
(Lautier et al., 1996
; Loe et al., 1996a
; Keppler and Arias, 1997
; Kusuhara et al., in press; Oude-Elferink
et al., 1995
; Yamazaki et al., 1993
) into
membrane vesicles prepared from MBEC4 cells. In addition, we examined
the expression of MRP along with that of cMOAT by Northern and Western
blot analyses.
| |
Materials and Methods |
|---|
|
|
|---|
Chemicals.
Unlabeled and [3H]DNP-SG
(50.0 µCi/nmol) were synthesized enzymatically using
[glycine-2-3H]glutathione (New England Nuclear,
Boston, MA), 1-chloro-2,4-dinitrobenzene and glutathione S-transferase
(Sigma Chemical Co., St. Louis, MO) as described previously (Kobayasi
et al., 1990
), and the purity was checked by thin-layer
chromatography.
[14,15,19,20-3H]LTC4 (128 µCi/nmol), [125I]sheep anti-mouse
immunoglobulin and [125I]sheep anti-rat
immunoglobulin antibodies were purchased from Amersham International
(Buckinghamshire, UK). Unlabeled LTC4 was purchased from Sigma. Rat anti-hMRP antibody, MRPr1 and mouse anti-human P-gp antibody, C219 were purchased from Kamiya Biomedical (Tukwila, WA) and Centocor (Malvern, PA), respectively. All other chemicals were commercially available, of reagent grade and used without further purification.
Cell lines.
MBEC4 cells, established by immortalizing the
isolated mouse brain capillary endothelial cells by SV40 infection
(Tatsuta et al., 1992
), were used in our study. The cells
were maintained in Dulbecco's modified Eagle's medium (low glucose)
supplemented with 10% fetal bovine serum in 5%
CO2-95% air at 37°C.
Membrane vesicle preparation.
All steps were performed at 0 to 4°C. Membrane vesicles were prepared by nitrogen cavitation from
MBEC4 cells according to the method described previously (Fujii
et al., 1994
) with minor modification. Cell monolayers were
washed and scraped into phosphate-buffered saline. The cells were
washed by centrifugation (4000 × g for 10 min) in
phosphate-buffered saline and then in buffer A (10 mM Tris-HCl, 250 mM
sucrose and 2 mM CaCl2, pH 7.5). The pellet was
stored at -100°C until required. The defrosted cells were equilibrated at 4°C under a nitrogen pressure of 63 kg/cm2 for 30 min, and then depressurized
rapidly. EDTA (final concentration 1 mM) and 3 volumes of buffer B (10 mM Tris-HCl and 250 mM sucrose, pH 7.5) were added to the lysed cell
suspension, then centrifuged at 1000 × g for 10 min at
4°C to remove nuclei and unlysed cells. The supernatant was layered
onto a 35% sucrose cushion (10 mM Tris-HCl, 35% sucrose and 1 mM
EDTA, pH 7.5) and centrifuged for 30 min at 16,000 × g
at 4°C. The interface was collected, diluted with 4 volumes of buffer
B and centrifuged at 100,000 × g for 45 min at 4°C.
The vesicle pellet was resuspended in buffer B using a 25-gauge needle.
Vesicles were stored at -100°C until required. The orientation of
membrane vesicles was determined by examining the nucleotide
pyrophosphatase in the presence and absence of 1% Triton X with
p-nitrophenyl-thymidine 5'-monophosphate as the substrate
(Böhme et al., 1994
).
|
Isolation of brain capillaries.
Capillaries were isolated
from Wistar rats (Male, 240-270 g; Nihon Ikagaku, Tokyo, Japan) using
the method described previously (Pardridge et al., 1985
)
with minor modification. After decapitation, the cerebrum was removed
quickly, rinsed with ice-cold buffer containing 122 mM NaCl, 25 mM
NaHCO3, 10 mM D-glucose, 3 mM KCl, 1.4 mM CaCl2, 1.2 mM MgSO4,
0.4 mM K2HPO4 and 10 mM
HEPES (pH 7.4). The minced cerebrum was homogenized with 2 volumes of
buffer using a glass/Teflon Potter homogenizer for five periods of 1 min each at 200 rpm. The homogenate was filtered through a 32-µm nylon mesh. Trapped brain capillaries were stored at -80°C until assayed.
Northern blot analysis.
Northern hybridization was performed
as described previously (Ito et al., 1996-1998). The cDNA
fragment encoding the carboxy-terminal ABC region of murine MRP was
amplified from MBEC4 cell RNA by RT-PCR using degenerated PCR primers
as described previously (Ito et al., 1998
). The cDNA
fragments containing the linker region of murine mdr1a and mdr1b
(nucleotide 1343-1476 and 1921-2098, respectively; Croop et
al., 1989
) were also prepared by RT-PCR, using RNA from ddy mouse
liver as a template. The amplified PCR products were subcloned into the
EcoR V site of pBluescript II SK(-) and then the sequence
was determined. The cDNA fragments were excised by digestion with
EcoRI and HindIII as the probe.
Western blot analysis. A total of 25 µg of the proteins of MBEC4 membrane vesicles and rat brain capillary was fractionated on a 7.5% (w/v) polyacrylamide slab gel containing 0.1% (w/v) SDS and then transferred onto a nitrocellulose filter by electroblotting. The filter was incubated for at least 1 hr in 10 mM Tris-HCl buffer (pH 8.0) containing 150 mM NaCl, 0.05% Tween-20 and 5% (w/v) bovine serum albumin for MRPr1 and in 10 mM Tris-HCl buffer (pH 8.0) containing 150 mM NaCl, 0.05% Tween-20 and 5% (w/v) milk powder for C219 to prevent nonspecific binding of antibodies. Then, it was incubated with MAbs (MRPr1, 1:50; C219, 1:100) for 12 hr, and with [125I] sheep anti-rat immunoglobulin and [125I]sheep anti-mouse immunoglobulin antibodies for 1 hr at room temperature in the same buffer. Filters were exposed to Fuji imaging plates for 3 h at room temperature and analyzed by a BAS imaging analyzer.
| |
Results |
|---|
|
|
|---|
Uptake of [3H]DNP-SG and [3H]LTC4 into membrane vesicles. Determination of nucleotide pyrophosphatase in the presence and absence of 1% Triton X revealed that 65% of the membrane vesicles were inside out. Figure 1 shows the time-profiles for the uptake of [3H]DNP-SG (1 µM) and [3H]LTC4 (2 nM) into membrane vesicles prepared from MBEC4 cells in the presence or absence of 5 mM ATP. The uptake of both ligands into membrane vesicles was stimulated by ATP (fig. 1).
|
Osmotic sensitivity of the uptake of [3H]DNP-SG into membrane vesicles. Osmotic sensitivity was studied by examining the uptake of [3H]DNP-SG into membrane vesicles in the presence of several concentrations of sucrose in the medium to confirm that a major part of the accumulation can be accounted for by transport into the intravesicular space, but not by binding to the vesicle surface. As shown in figure 2, the uptake of [3H]DNP-SG at steady-state was reduced as the sucrose concentration in the medium increased. The y-intercept for the relationship between the amount of DNP-SG associated with the vesicles versus the reciprocal of the sucrose concentration in the medium was 5.5 µl/mg protein (fig. 2). The amount of DNP-SG bound to the vesicle surface was less than 10% of the total vesicle uptake, if the transport experiment was performed in isotonic medium.
|
Nucleotide specificity of [3H]DNP-SG uptake into membrane vesicles. Nucleotide specificity of [3H]DNP-SG uptake was examined by replacing ATP by other nucleotides. As shown in table 1, DNP-SG uptake was most efficient with ATP, but not ADP or AMP. GTP was to some extent also able to stimulate the uptake of [3H]DNP-SG into membrane vesicles prepared from MBEC4 cells. One hundred micromolar vanadate, an inhibitor of ATPases, reduced the ATP-dependent uptake of [3H]DNP-SG to 60% of the control value.
|
Kinetics of the uptake of [3H]DNP-SG and [3H]LTC4 into membrane vesicles. To obtain the kinetic parameters (Km and Vmax), the saturation of the ATP-dependent uptake of [3H]DNP-SG and [3H]LTC4 into membrane vesicles was examined (fig. 3). Nonlinear regression analysis yielded Km values of 0.557 ± 0.066 µM and 0.221 ± 0.047 µM, and Vmax values of 5.47 ± 2.66 pmol/min/mg protein and 27.5 ± 3.9 pmol/min/mg protein for DNP-SG and LTC4, respectively. The fit in figure 3b seems poor. Due to the saturation, the transport in the presence and absence of ATP was similar at higher concentrations of LTC4 and this fact resulted in the poor fit along with the large deviations in Vmax.
|
Northern and Western blot analyses.
The expression of cMOAT
and MRP in MBEC4 cells was examined by Northern blot analysis. As shown
in figure 4, murine MRP probe hybridized
with poly A+ RNA from MBEC4 cells at the same
location (6.0 kb) as that reported previously (Stride et
al., 1996
). In contrast, no band was observed if a cMOAT probe was
used, although two bands (6.0 and 8.2 kb) were detected in BALB/C mouse
liver (data not shown). Furthermore, RT-PCR failed to amplify the cMOAT
cDNA fragment with MBEC4 cDNA.
|
| |
Discussion |
|---|
|
|
|---|
We examined the presence of an efflux transporter on the BBB for
organic anions by examining the transport of DNP-SG and
LTC4, typical substrates of cMOAT and MRP, into
membrane vesicles prepared from MBEC4 cells. ATP stimulated the uptake
of [3H]DNP-SG and [3H]
LTC4 into membrane vesicles (fig. 1). This
ATP-dependent uptake was osmotically sensitive (fig. 2), suggesting
that the major part of the uptake of [3H]DNP-SG
is actually due to uptake, and not adsorption to membrane vesicles.
Because 1) ATP-dependent uptake of [3H]DNP-SG
was inhibited by vanadate and 2) ADP or AMP did not stimulate the
uptake of [3H]DNP-SG (table 1), the uptake of
[3H]DNP-SG requires hydrolysis of ATP. Not only
ATP but also GTP could stimulate the uptake of
[3H]DNP-SG into membrane vesicles (table 1),
which is consistent with a previous observation in rat bile canalicular
membrane vesicles (Ballatori and Truong, 1995
; Kobayashi et
al., 1990
) and in membrane vesicles prepared from hMRP-transfected
HeLa cells (Loe et al., 1996b
). These results indicate that
MRP/cMOAT activity is associated with the plasma membrane of MBEC4
cells. Because Northern and Western blot analyses suggest the
expression of MRP in MBEC4 cells, it is plausible that the transport
activity is mediated, at least in part, by MRP. In principle, the
ATP-dependent uptake of ligands can be ascribed to uptake into inside
out membrane vesicles that account for 65% of the prepared vesicles,
and therefore, the transport observed in vitro represents
efflux of ligands from cells under physiological conditions.
Kinetic parameters for the uptake of DNP-SG and
LTC4 should be compared in several cell lines.
Because 1) the ATP-dependent uptake of these glutathione conjugates
into membrane vesicles from MBEC4 cells consisted of one saturable
component (fig. 3), and 2) Northern and Western blot analyses indicated
the expression of MRP but not cMOAT in MBEC4 cells (fig. 4), the
Michaelis constants determined in our study may represent the
Km value of the respective ligands
for MRP. Kinetic analysis revealed that the
Km value for DNP-SG uptake into
MBEC4 membrane vesicles was 0.56 µM (fig. 3), which was consistent
with that determined in membrane vesicles prepared from murine leukemia
cells, L1210 (Km = 0.6 µM) (Saxena and
Henderson, 1995
). In addition, Saxena and Henderson (1995)
found that
LTC4 inhibits the ATP-dependent uptake of
[3H]DNP-SG into membrane vesicles from L1210
with a Ki of .20 µM, which is also
consistent with the Km of the
ATP-dependent uptake of LTC4 into MBEC4 membrane
vesicles (Km = 0.22 µM) (fig. 3). Collectively, the transport properties of primary active transporter(s) expressed on L1210 and MBEC4 cells resemble each other kinetically. Kinetic parameters determined in these mouse cell lines, however, were
different from those reported for hMRP. Jedlitschky et al. (1996)
determined the kinetic parameters for the uptake of DNP-SG and
LTC4 in hMRP-transfected HeLa cells and found
that the affinity of LTC4 (0.097 µM) for hMRP
is approximately 40-fold higher than that of DNP-SG (3.6 µM). Because
the Vmax values of LTC4 and
DNP-SG for hMRP are 100 and 409 pmol/min/mg protein in hMRP-transfected HeLa cells, respectively, the clearance for the uptake at tracer concentrations (CLuptake) defined as the
Vmax/Km of
LTC4 (1031 µl/min/mg protein) is much higher
than that of DNP-SG (114 µl/min/mg protein) (Jedlitschky et
al., 1996
). Although the CLuptake of LTC4 (124 µl/min/mg protein) was approximately
13-fold higher than that of DNP-SG (9.82 µl/min/mg protein) in MBEC4
vesicles, this difference is ascribed predominantly to the difference
in Vmax values between the two ligands (27.5 pmol/min/mg protein and 5.47 pmol/min/mg protein for
LTC4 and DNP-SG, respectively). Collectively,
these results suggest that the transport characteristics of MRP may be
different in mice and humans. Such a difference in the transport
properties of MRP between mice and humans has been reported previously.
Stride et al. (1997)
examined the resistance of murine and
human MRP-transfected HEK293 cells to anti-tumor drugs and found that
murine and human MRP conferred similar resistance profiles with the
exception that only hMRP conferred resistance to anthracyclines. In
addition, the accumulation of [3H]vincristine
and [3H]VP-16 was reduced and efflux of
[3H]vincristine was increased in both murine
and human MRP-transfectants, although only hMRP-transfectants displayed
reduced accumulation and increased the efflux of
[3H]daunomycin (Stride et al.,
1997
).
Although expression of MRP in the brain was reported using RNase
protection assay/Northern blot analysis (Flens et al., 1996
; Stride et al., 1996
), localization in the brain has not been
examined. Western blot analysis revealed that MRP or closely related
protein is expressed on the rat brain capillary (fig. 4). Although the localization of this protein on brain capillary endothelial cells (luminal or antiluminal) has not been clarified yet, the results of the
present study are consistent with the hypothesis that MRP and/or its
related protein, along with P-gp, mediates the efflux of xenobiotics
from the CNS. Because 1) glucuronide and glutathione conjugates are
substrates for MRP (Lautier et al., 1996
; Loe et al., 1996a
) and 2) UDP-glucuronosyl transferase and
glutathione-S-transferase are expressed in brain parenchyma and
cerebral endothelial cells (Ghersi-Egea et al., 1994
), it is
plausible that the conjugated metabolites formed in the CNS are
transported to the blood across the BBB. The presence of such a
sequential detoxification of xenobiotics by metabolic enzymes and
efflux transporter(s) in the liver has been suggested (Ishikawa, 1992
).
Based on the results of the transport studies in normal rats (such as
Sprague-Dawley and Wistar strains) and mutant rats whose cMOAT function
is hereditarily defective (such as Eisai hyperbilirubinemic and
TR
strains), we and others have demonstrated
that the substrate for cMOAT includes glutathione conjugates (such as
DNP-SG, LTC4 and glutathione disulfide) and
glucuronide conjugates (such as glycyrrhizin, glucuronides of bilirubin
and 6-hydroxy 5,7-dimethyl-2-methylamino-4-(3-pyridylmethyl) benzothiazole dihydrochloride and liquiritigenin) (Lautier et al., 1996
; Leier et al., 1994
; Loe et al.,
1996a
; Keppler and Arias, 1997
; Kusuhara et al., in press;
Oude-Elferink et al., 1995
; Yamazaki et al.,
1993
). In addition, we demonstrated that the nonconjugated compounds
such as pravastatin, temocaprilat, cefodizime and the carboxylate form
of CPT-11 and SN-38 are extruded via cMOAT (Kusuhara et al.,
in press; Yamazaki et al., 1993
). Because the substrate
specificity of cMOAT and MRP is similar (Lautier et al.,
1996
; Loe et al., 1996a
; Keppler et al., 1997
; Kusuhara et al., in press; Oude-Elferink et al.,
1995
; Yamazaki et al., 1993
), it is plausible that the
penetration of these compounds into the brain is restricted by MRP
expressed on cerebral capillary endothelial cells. Although Cornford
et al. (1985)
and Masereeuw et al. (1994)
along
with Takasawa et al. (1997)
reported active efflux of
valproic acid and 3'-azide-3'-deoxythymidine across the BBB by
examining the time-dependent change in the brain uptake index and by
examining the elimination after administration into the cerebral
cortex, respectively, it remains to be established whether these
ligands are actively transported across the BBB via MRP.
In conclusion, our study demonstrated the expression of MRP on MBEC4 cells, retaining BBB properties. It is possible that the expression of such efflux transporter(s) along with the presence of metabolic enzymes endows cerebral endothelial cells with the ability to detoxify xenobiotics thereby providing a blood-brain barrier function.
| |
Footnotes |
|---|
Accepted for publication February 24, 1998.
Received for publication October 13, 1997.
Send reprint requests to: Dr. Yuichi Sugiyama, Faculty of Pharmaceutical Sciences, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo 113, Japan.
| |
Abbreviations |
|---|
BBB, blood-brain barrier; CNS, central nervous system; MRP, multidrug resistance associated protein; P-gp, P-glycoprotein; DNP-SG, 2,4-dinitrophenyl-S-glutathione; LTC4, leukotriene C4; hMRP, human multidrug resistance associated protein; cMOAT, canalicular multispecific organic anion transporter; ATP, adenosine 5'-triphosphate; AMP, adenosine 5'-monophosphate; GTP, guanosine 5'-triphosphate; SDS, sodium dodecyl sulfate.
| |
References |
|---|
|
|
|---|
-D-glucuronide.
J Neurochem
56:
1163-1168[Medline].This article has been cited by other articles:
![]() |
J. Enokizono, H. Kusuhara, A. Ose, A. H. Schinkel, and Y. Sugiyama Quantitative Investigation of the Role of Breast Cancer Resistance Protein (Bcrp/Abcg2) in Limiting Brain and Testis Penetration of Xenobiotic Compounds Drug Metab. Dispos., June 1, 2008; 36(6): 995 - 1002. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhang, J. D. Schuetz, W. F. Elmquist, and D. W. Miller Plasma Membrane Localization of Multidrug Resistance-Associated Protein Homologs in Brain Capillary Endothelial Cells J. Pharmacol. Exp. Ther., November 1, 2004; 311(2): 449 - 455. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Qiu, T. F. Kalhorn, and J. T. Slattery ABCC2-Mediated Biliary Transport of 4-Glutathionylcyclophosphamide and Its Contribution to Elimination of 4-Hydroxycyclophosphamide in Rat J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 1204 - 1212. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Daidoji, H. Inoue, S. Kato, and H. Yokota GLUCURONIDATION AND EXCRETION OF NONYLPHENOL IN PERFUSED RAT LIVER Drug Metab. Dispos., August 1, 2003; 31(8): 993 - 998. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. T. Ronaldson and R. Bendayan Renal Drug Transport and Drug-Drug Interactions Journal of Pharmacy Practice, December 1, 2002; 15(6): 490 - 503. [Abstract] [PDF] |
||||
![]() |
K. A. Witt, J. D. Huber, R. D. Egleton, and T. P. Davis Pluronic P85 Block Copolymer Enhances Opioid Peptide Analgesia J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 760 - 767. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Yan and E. M. Taylor Neotrofin Is Transported Out of Brain by a Saturable Mechanism: Possible Involvement of Multidrug Resistance and Monocarboxylic Acid Transporters Drug Metab. Dispos., May 1, 2002; 30(5): 513 - 518. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Lee, S. Dallas, M. Hong, and R. Bendayan Drug Transporters in the Central Nervous System: Brain Barriers and Brain Parenchyma Considerations Pharmacol. Rev., December 1, 2001; 53(4): 569 - 596. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. H. DeCory, K. M. Piech-Dumas, S.-S. Sheu, H. J. Federoff, and M. W. Anders Efflux of Glutathione Conjugate of Monochlorobimane from Striatal and Cortical Neurons Drug Metab. Dispos., October 1, 2001; 29(10): 1256 - 1262. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Sugiyama, H. Kusuhara, Y. Shitara, T. Abe, P. J. Meier, T. Sekine, H. Endou, H. Suzuki, and Y. Sugiyama Characterization of the Efflux Transport of 17beta -Estradiol-D-17beta -glucuronide from the Brain across the Blood-Brain Barrier J. Pharmacol. Exp. Ther., July 1, 2001; 298(1): 316 - 322. [Abstract] [Full Text] |
||||
![]() |
D. S. Miller, S. N. Nobmann, H. Gutmann, M. Toeroek, J. Drewe, and G. Fricker Xenobiotic Transport across Isolated Brain Microvessels Studied by Confocal Microscopy Mol. Pharmacol., April 13, 2001; 58(6): 1357 - 1367. [Abstract] [Full Text] |
||||
![]() |
B. Vulevic,, Z. Chen, J. T. Boyd, W. Davis Jr., E. S. Walsh, M. G. Belinsky, and K. D. Tew Cloning and Characterization of Human Adenosine 5'-triphosphate-binding Cassette, Sub-family A, Transporter 2 (ABCA2) Cancer Res., April 1, 2001; 61(8): 3339 - 3347. [Abstract] [Full Text] |
||||
![]() |
I. Tamai, J. Yamashita, Y. Kido, A. Ohnari, Y. Sai, Y. Shima, K. Naruhashi, S. Koizumi, and A. Tsuji Limited Distribution of New Quinolone Antibacterial Agents into Brain Caused by Multiple Efflux Transporters at the Blood-Brain Barrier J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 146 - 152. [Abstract] [Full Text] |
||||
![]() |
M. V. St-Pierre, M. A. Serrano, R. I. R. Macias, U. Dubs, M. Hoechli, U. Lauper, P. J. Meier, and J. J. G. Marin Expression of members of the multidrug resistance protein family in human term placenta Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1495 - R1503. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Nishino, H. Suzuki, D. Sugiyama, T. Kitazawa, K. Ito, M. Hanano, and Y. Sugiyama Transepithelial Transport of Organic Anions across the Choroid Plexus: Possible Involvement of Organic Anion Transporter and Multidrug Resistance-Associated Protein J. Pharmacol. Exp. Ther., July 1, 1999; 290(1): 289 - 294. [Abstract] [Full Text] |
||||
![]() |
M. Homma, H. Suzuki, H. Kusuhara, M. Naito, T. Tsuruo, and Y. Sugiyama High-Affinity Efflux Transport System for Glutathione Conjugates on the Luminal Membrane of a Mouse Brain Capillary Endothelial Cell Line (MBEC4) J. Pharmacol. Exp. Ther., January 1, 1999; 288(1): 198 - 203. [Abstract] [Full Text] |
||||
![]() |
T. Kitazawa, T. Terasaki, H. Suzuki, A. Kakee, and Y. Sugiyama Efflux of Taurocholic Acid Across the Blood-Brain Barrier: Interaction with Cyclic Peptides J. Pharmacol. Exp. Ther., August 1, 1998; 286(2): 890 - 895. [Abstract] [Full Text] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||